Companies / LDX

LUMOS DIAGNOSTICS HOLDINGS LIMITED

ASX:LDXHealth Care Equipment & Services
944.8M shares on issueAppendix 2A · as of 27 July 2026$0.10price · delayed$103.9Mmarket cap · indicative
C
Dilution grade

Share count grew 96% in 24 months; 4 cash raises in 24 months; options/rights overhang 27% of shares

Cash runway12.0 quarters of funding
Share-count growth (24m)96.3%
Raise cadence (24m)4 cash raises
Options & rights overhang27.3% of shares
In-the-money supply15.8% of shares
Pending proposed issuesnone

LUMOS DIAGNOSTICS HOLDINGS LIMITED's ordinary share count grew 96.3% between April 2024 and July 2026, to 945M shares. The company raised capital four times in that period for total proceeds of A$60.6M, most recently a A$20.3M Placement / Share Purchase Plan in March 2026. Options and rights on issue could convert into 258M new shares, equal to 27.3% of the current share count, of which 16% are in the money at the current share price; the nearest expiry is August 2026. At the June 2026 quarter the company reported A$15.0M in cash, covering 12.0 quarters at its recent spending rate. There are no proposed securities issues (Appendix 3B) currently pending.

AI-generated summary of this page's cited filings · updated 28 July 2026
Email me when this grade changes
Alerts are coming soon — this opens a pre-filled email that puts you on the list.
27.3%
Max option dilution
15.8%
ITM option dilution
2
Raises · last 12 months
12.0 qtrs
Cash cover · over 4 quarters

Shares on issue — last 2 years

Ordinary shares on issue
Weekly counts from ASX records. Dots mark cash capital raises. Latest count 944.8M per Appendix 2A (27 July 2026).
787.5M845.1M902.7MDec 24Sept 25July 26Cash raise · 24 Mar 2026Cash raise · 24 Mar 2026

Cash runway

12.0 qtrs
More than four quarters of funding at the recent spend rate.
$15.0M available cash at quarter ended 30 June 2026 · Runway is computed from Appendix 4C/5B filings and announced raise proceeds.
Paid plan
Cash runway history
Quarterly cash, net spend and cover trend from every Appendix 4C/5B on record up to 30 June 2026.
Join the waitlist

Issuance timeline

Latest 5 filings (Appendix 2A quoted issues, 3G unquoted, 3H cancellations)

DateFormSecurityTotal on issue afterSource
27 July 20262A · quoted issueLDX : ORDINARY FULLY PAID944.8MAppendix 2A
14 July 20263H · cancellationLDX : ORDINARY FULLY PAID944.4MAppendix 3H
22 June 20262A · quoted issueLDX : ORDINARY FULLY PAID944.4MAppendix 2A
20 May 20262A · quoted issueLDX : ORDINARY FULLY PAID929.2MAppendix 2A
1 May 20262A · quoted issueLDX : ORDINARY FULLY PAID923.9MAppendix 2A
Paid plan
Full issuance history
Every quoted and unquoted issue and cancellation on record, plus unquoted securities (Appendix 4.2).
Join the waitlist

Capital raises

4 cash raises in the last 24 months · 2 in the last 12 months

$20.3M
Placement / Share Purchase Plan (SPP)
24 Mar 2026 COMPLETE
Paid plan
Full raise history
Issue price, discount, brokers, purpose and tranche detail for every raise on record.
Join the waitlist

Pending proposed issues

No proposed issues (Appendix 3B) currently pending.

Options & convertible securities

27.3%
Total overhang · of current shares
15.8%
In the money · at current price
257.8M
Potential new shares
Aug 2026
Nearest expiry
Paid plan
Per-line options & expiry cliffs
Each option line — code, strike, expiry, quantity and ITM value — plus the expiry-cliff chart.
Join the waitlist

Director dealings

DateDirectorTypeSharesOptionsValueSource
24 July 2026DOUG WARDOther4.1M——3Y notice
16 June 2026Catherine RobsonBuy300k—$31k3Y notice
2 June 2026DOUG WARDOther3.7M——3Y notice
Paid plan
Full dealing history
Every change-of-director's-interest notice on record, with direction and consideration.
Join the waitlist

Ownership

Free account
Top-20 holders & substantial holder notices
Top-20 register snapshot and substantial-holder movements, each linked to its source notice.
Sign up free — coming soon

Latest announcements

28 July 2026Change of Director's Interest Notice - DW
27 July 2026Section 708A Cleansing Statement
27 July 2026Application for quotation of securities - LDX
27 July 2026Investor Presentation
26 July 2026$PQuarterly Activities/Appendix 4C Cash Flow Report
21 July 2026$PFebriDx Commercial Traction Across Priority US Accounts
20 July 2026Q4 FY26 Results Release Date and Webinar Invitation
20 July 2026Investor Information Sessions
14 July 2026Notification of cessation of securities - LDX
2 July 2026Closure of A$5M Loan Facility with Major Shareholders
28 June 2026$PLumos Receives Research & Development Tax Rebate
25 June 2026Change of Director's Interest Notice - SL
22 June 2026Application for quotation of securities - LDX
18 June 2026Change of Director's Interest Notice - CR
10 June 2026Investor Presentation - FebriDx US Commercial Update
5 June 2026Change of Director's Interest Notice - DW
4 June 2026FebriDx US Commercial Update Webinar Invitation
20 May 2026Application for quotation of securities - LDX
20 May 2026Section 708A Cleansing Statement
18 May 2026$PFebriDx U.S. Rollout and Reimbursement Update - Amended

Headlines link to the source PDFs on the ASX announcements platform. Data as of 28 July 2026.